Skip to main content
Home
  • News
  • Events
  • Funding
  • Members
    • Human Subjects Research
      HCC centrally manages cancer-related human subjects research via a central IRB. Visit this section for guidance and education.
      • HCC Staff Onboarding & Training
      • Treatment Research
      • Non-Treatment Research
      • Document Library
      • Research Informatics Operations
      • Office of Data Quality
      • Office for Human Research Studies
      • Office of Research Integrity and Compliance
    • Core Facilities
      HCC funds several Core facilities offering unique services and/or discounted rates to HCC members.
      • Bioinformatics Training
      • Biostatistics
      • Cancer Proteomics
      • Cell Manipulation
      • Mouse Engineering
      • Health Communication
      • Research Pharmacy
      • Survey and Qualitative Methods
      • Tumor Imaging Metrics
      • Rodent Histopathology
      • Specialized Histopathology
      • Tissue Microarray and Imaging
      • Spatial Technologies Unit
      • Tumor Cartography
    • Research Programs
      Research collaboration in the Consortium is organized into several programs.
      • Breast Cancer
      • Cancer Care Delivery Research
      • Cancer Cell Biology
      • Cancer Data Sciences
      • Cancer Epidemiology
      • Cancer Genetics and Epigenetics
      • Cancer Immunology
      • Cancer Risk, Prevention, and Early Detection
      • Developmental Therapeutics
      • Kidney Cancer
      • Leukemia
      • Lung Cancer
      • Lymphoma and Myeloma
      • Melanoma
      • Neuro-Oncology
      • Prostate Cancer
    • HCC SPOREs
      HCC is home to several NCI Specialized Programs of Research Excellence (SPOREs)
      • Brain Cancer
      • Breast Cancer
      • Kidney Cancer
      • Lung Cancer
      • Leukemia
      • Prostate Cancer
    • About HCC
      • Our Mission
      • Member Institutions
      • Leadership & Administration
      • HCC Offices
    • HCC Offices
      • Administration
      • COE
        Community Outreach & Engagement
      • Communications
      • OHRS
        Office for Human Research Studies
      • ODQ
        Office of Data Quality
      • Pathfinder
      • RIO
        Research Informatics Operations
    • Training
      Training programs and resources for researchers of all levels
    • Go to page:
      • High School, College, Postbacc
      • Graduate Students
      • Postdoc & Early-Career
    • Pathfinder
      Training and career development opportunities for early-stage researchers
    • Mentoring with CURE
      HCC members are always needed to help mentor the next generation as part of the CURE student training programs
  • Community Outreach
    • Human Subjects Research
      HCC centrally manages cancer-related human subjects research via a central IRB. Visit this section for guidance and education.
    • Core Facilities
      HCC funds several Core facilities offering unique services and/or discounted rates to HCC members.
    • Research Programs
      Research collaboration in the Consortium is organized into several programs.
    • HCC SPOREs
      HCC is home to several NCI Specialized Programs of Research Excellence (SPOREs)
    • About HCC
    • Training
      Training programs and resources for researchers of all levels
    • Pathfinder
      Training and career development opportunities for early-stage researchers
    • Mentoring with CURE
      HCC members are always needed to help mentor the next generation as part of the CURE student training programs
  • Community Outreach
  • News
  • Events
  • Funding
  • Members
  1. Events
  2. Previous Years
  • Overview
  • Frequently Asked Questions
  • Previous Years
  • Register
  • Submit Abstracts
  • Contact Us

Previous Year Event Recaps

November 4, 2025 | 1:00 - 5:00 pm

Keynote Speaker:

Jane J Kim, PhD
KT Li Professorship in Health Economics
Harvard TH Chan School of Public Health

2025 Award Winners 

Best Oral Presentation: Analí Castellanos-Gutiérrez

Most Innovative Idea: Lauren Finkelstein

Best Poster Presentation: James Duffy

  • 2025 Agenda

     

    1:00 – 1:10 pm (10 minutes)

    Welcome and Introductions

    Ramesh Shivdasani, MD, PhD, Deputy Director of the HCC
    Lorelei A. Mucci, ScD, MPH, Associate Director of the Population Science Programs at the HCC


    1:10 – 1:50 pm (40 minutes)

    Keynote Speaker

    Jane J Kim, PhD
    KT Li Professorship in Health Economics at the Harvard TH Chan School of Public Health
    Visit Profile

    "Cervical Cancer Prevention: The Quintessential and Persistent Public Health Challenge"

    Abstract:
    Effective and cost-effective preventive strategies against cervical cancer have been available for several decades. HPV vaccination and cervical cancer screening hold such promise that the World Health Organization Director General issued a call for the global elimination of cervical cancer as a public health problem in 2018. Despite these available options, cervical cancer remains hugely burdensome with wide disparities in incidence and mortality around the globe, and even within the United States.
    This talk chronicles the progress towards cervical cancer elimination over the past two decades and the many remaining challenges. I discuss this quintessential public health problem from the lens of decision sciences as an approach to evidence-based decision making that has informed policy recommendations for HPV vaccination and cervical cancer screening in the United States and globally. Professional development and lessons learned through research collaborations, which were found to be portable to leadership roles more broadly, are shared.


    1:50 – 2:35 pm (45 minutes)

    Oral Presentation Session I

    Rebecca Bromley-Dulfano, MS: Integration of Safety Net Hospitals into Healthcare Systems and Specialty Care Access
    Analí Castellanos-Gutiérrez, MD, MS: Adherence to the planetary health diet and the risk of breast cancer in the Pooling Project of Prospective Studies of Diet and Cancer
    Derek Chang, BA: Clinical and Genomic Characteristics of Post-Colonoscopy Colorectal Cancer
    Ashley Odai-Afotey, MD: Early postoperative opioid fills after cancer-directed surgery among Medicare beneficiaries by race and ethnicity
    Xinan Wang, MS: AI-Derived Body Composition Analysis Reveals Muscle Volume and Metformin-Associated Adipose Effects and the Obesity Paradox in Non-Small Cell Lung Cancer


    2:35 – 3:00 pm (25 minutes)

    Break


    3:00 – 3:45 (45 minutes)

    Oral Presentation Session II

    Fuyu Guo, MS: Taking into account the susceptible window for exposures in Cox proportional hazard Model: a new model using splines to model the lag-risk relationship
    Priyanka Gautom, PhD, MPH: The Role of Community Advisory Boards at NCI-Designated Cancer Centers: Findings from a Qualitative Analysis
    Austin Waters, PhD, MSPH: Multi-Level Anti-LGBTQ+ Stigma and Hypervigilance and Health Outcomes Among LGBTQ+ Cancer Caregivers
    Kathryn Post, PhD, RN: Improving endocrine therapy initiation and breast cancer care equity with a nurse-led, culturally sensitive intervention


    3:45 – 5:15 pm (1 hour, 30 minutes)

    Poster Session and Reception

    Isaac Allen, PhD: Initiation of Active Surveillance, and Continuation from Active Surveillance to Curative Treatment, in A Cohort of Health Professionals Diagnosed with Low and Favorable-Intermediate Risk Prostate Cancer
    Kiana Angalia, BS: Pilot Randomized Trial of An Informational and Supportive Care Intervention for Patients Initiating Multimodality Therapy For Locally Advanced Rectal Cancer (LARC).
    Yufeng Chen, MD, PhD: Polygenic Risk Score and Risk of Post-Colonoscopy Colorectal Cancer and High-Risk Polyps
    Cami Christopher, MPH: Perceived Barriers to Diet and Exercise among Survivors of Pediatric Brain and Central Nervous System Tumors
    Michelle Chudnovsky: Cardiorespiratory Fitness Among Hispanic/Latina Breast Cancer Survivors: A Comparison with Age-Matched Women
    Elizabeth Cox, PhD: Physical Activity and Bone Fracture Risk in a Cohort of Prostate Cancer Patients: Results from the Health Professionals Follow-up Study
    James Duffy, BS: BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation
    Xin Fang, PhD: Metals Metabolites Linked to Reproductive Aging: A Mixture and Machine Learning Approach, NHANES 2003-2018
    Yile Fang, PhD: Head-to-Head Comparison of Analog-Filament Vs Digital-CNT X-ray Sources
    Lauren Finkelstein, MA: Writing Content Predicts Cancer-Related Trauma and Fear Outcomes in Written Exposure to Worst-Case Scenarios for Advanced Cancer
    Anna Flynn, BS: They’re in Control: A Descriptive Analysis of AIM Trial Control Participants Electing the Exercise Intervention After the Study Period
    Jifan Gao, PhD: Count-Based Approaches Remain Strong: A Benchmark Against Transformer and LLM Pipelines on Structured EHR
    Connor Grady, MPH: Comparing Strategies of Abiraterone Vs. Enzalutamide For Risk of Mortality in Advanced Prostate Cancer: A Target Trial Emulation Using Data From the IRONMAN Registry  
    Yoon Sik Jung, BS: Cancer FactFinder: Translating Scientific Evidence to Address Cancer Misinformation
    Roka Kakehi, MS: A Meta-Analysis on the Association between Yogurt Consumption and Risk of Colorectal Cancer by Anatomic Site of Colon and Calcium Intake
    René Karadakic, PhD: The Value of (Sub) Specialization: Evidence from Oncology
    Li-Wei Kuo, PhD: c-MET enrichment in STAS cells Disseminated From Early-Stage NSCLC
    Phuong Anh Le, MS: Adherence to the EAT-Lancet Reference Diet in Adolescence and Risk of Invasive Breast Cancer Among US Women
    Zichao Li, PhD: Does Medicaid Expansion Help to Close Breast Cancer Mortality Gap? A Difference-In-Differences Analysis
    Nan Lin, PhD: The Role of Distress-related Metabolic Dysfunction in Ovarian Cancer Development
    Shupeng Luxu: GeneGrad: Geometric Gradient-Based Biomarker Discovery in Single-Cell Transcriptomics
    Yue Ma, PhD: Comparative Assessment of Risk Factors for Colorectal Polyps and Cancer, and the Transition from Colorectal Polyps to Cancer
    Jennifer Marks, MD: MTAP Deficiency in Thymic Epithelial Tumors
    Colleen McGrath, SM: The Association Between Coping and Social Resilience Factors with Psychiatric Morbidity During Cancer Survivorship in the Stress and Gene Analysis (SAGA) Cohort
    Xiang Meng, PhD: A Doubly Robust Estimator for Ratio and Difference in Average Hazard: Improving Interpretability and Reliability in Survival Analysis
    Alexis Miranda, MS: An Intersectional Approach to Cancer Disparities Research: Evaluating the Potential of MAIHDA Models as a Method for Disparity Identification
    Ana Nogal, PhD: Gut Microbial and Metabolic Alterations Preceding Colorectal Polyp Diagnosis
    Brett Ranieri, MPH: Impact of a Structured Exercise Program on Shoulder Range of Motion in Latina and/or Hispanic Breast Cancer Survivors
    Mónica Robles Fontan, MA: Adjusting for Exposure Misclassification in Time-Varying Vaccine Effectiveness Studies
    Andrea Romanos-Nanclares, PhD: Cruciferous Vegetable Intake, Dietary Glucosinolate and Risk of Breast Cancer in 2 Large Prospective Studies
    Emmanuelle Rosenthal, MPH: Self-Conscious Emotions and Personal Identity after Cancer: Pride, Shame, and Guilt among Young Adult Survivors
    Niloufar Saririan, BS: Inverse-Probability Weighting for Selection Bias in Tumor Biomarker Studies
    Swapnil Vallecha, BS: Effect of Proximity to Physical Activity Facilities on Anthropometric Measures in Breast Cancer Survivors
    Ian Vasicka, MD: Women Living with HIV (WLWH) in Sub-Saharan Africa: A Vulnerable Population with Increased Susceptibility to Cervical Cancer
    Emily Walsh, PhD: Characteristics Associated with Quality of Life, Anxiety, and Depressive Symptoms among Caregivers of Patients with Advanced Lung Cancer
    Qin Wang, PhD: Targeting Etiological HPV Cell-Free DNA in Blood for Early Detection of HPV Cancers and Precancers
    Bingxian Xu, PhD: Towards the Construction of a Virtual Cell
    Ruolin Zhang, MS: Obesity Genetic Risk and Ultra-processed Food Consumption on Long-Term Weight Change: A Gene-Environment Interaction Analysis in the Women's Genome Health Study


    5:15 pm

    Award Announcement

    Best Oral Presentation
    Most Innovative Idea
    Best Poster Presentation

December 3, 2024 | 1:00 - 5:00 pm

Keynote Speaker:

Scout, PhD, MA
Executive Director of the National LGBT Cancer Network

2024 Award Winners

Best Oral Presentation: Noah Chigier (DFCI) and Brett Ranieri (DFCI)

Most Innovative Idea: Phillip Nicol (HU)

Best Poster Presentation: Kelcie Willis (MGH)

  • 2024 Agenda

    1:00 – 1:10 pm (10 minutes)

    Welcome and Introductions

    Ramesh Shivdasani, MD, PhD, Deputy Director of the HCC

    Lorelei A. Mucci, ScD, MPH, Deputy Associate Director of the Population Science Programs at the HCC

    Brittany M. Charlton, ScD, Co-leader of the Cancer Epidemiology Program at the HCC


    1:10 – 2:00 pm (50 minutes)

    Keynote Speaker

     

    Scout, PhD, M.A.
    Executive Director of the National LGBT Cancer Network
    Visit Profile

    Talk Title: When Your Career Is Both Your Passion Project & A Political Football

    Abstract: I completed my PhD in Sociomedical Sciences with a concentration on LGBTQI+ health right as we changed over from one of the most welcoming presidential administrations to one of the most hostile on this topic to date - things were looking grim about my professional prospects. Perhaps because of this I moved into using my and other people's research to forward policy advocacy for my communities. En route to today I learned a lot about how policy is usually shaped by the experts in our field, experts like yourselves; how to poke the head of NIH enough until he starts asking you to serve; and the power of ghostwriting to change the world. Much of this work is necessarily very quiet, since the best policy moves leave someone else thinking they had the good idea. So come learn how scientists and clinicians are needed on the advocacy landscape and how you can multiply your community impact regardless of who's using your passion project as a political football.


    2:00 – 2:45 pm (45 minutes)

    Oral Presentation (part 1)

    Cong Wang, PhD, MPH: Inflammatory proteomic signatures of metabolically unhealthy obesity

    Ava Kikut-Stein, PhD: A community based participatory research approach to promoting equity in adolescent and young adult cancer communication

    Sarah Piombo, PhD, MPH: The impact of community connectedness on tobacco refusal skills among youth in India from low socio-economic backgrounds

    Noah Chigier, BKin and Brett Ranieri, BA: Impact of fatigue and sleep quality on exercise adherence among Latina and/or Hispanic breast cancer survivors


    2:45 – 3:00 pm (15 minutes)

    Break


    3:00 – 3:45 (45 minutes)

    Oral Presentation (part 2)

    LeeAnn Lucas, MS: Early-life risk factors and higher-grade prostate cancer

    Phillip Nicol, MA: Phylogeographic-based estimation of tumor cell motility from spatially resolved single-cell sequencing data

    Yuliya Leontyeva, PhD: Selection bias built into hazard ratios – an empirical demonstration in a large precision oncology trial

    Carmen Rodriguez Cabrera, AM, MPH: A Bayesian mixture model approach to examining neighborhood social determinants of health disparities in endometrial cancer treatment in Massachusetts

    Yoshitaka Nishikawa, MD, PhD: Thyroid screening outcomes and stable iodine intake among children after the 2011 Fukushima Nuclear Power Plant accident in Japan.


    3:45 – 5:00 pm (1 hour, 15 minutes)

    Poster Session and Reception
    [Poster Abstract Booklet]

    Hanan Abdelrahman, PhD: Symptoms prevalence and quality of life among cancer survivors in Oman

    Mina Bakhtiar, MD: Substance use, cancer incidence, and mortality among Medicare beneficiaries

    Mary Boulanger, MD: Pilot feasibility trial of a supportive care digital application “THRIVE” for patients with advanced non-small cell lung cancer

    Maria Bustamante Molina, BS: The impact of gender-affirming care on cancer risk and screening practices in transgender populations: a narrative review

    Xueying Chen, BS: Fam3PRO: A web-based user interface for a multi-gene, multi-cancer risk prediction model for families with cancer history

    Nick Falkenberg, BA: Ambient PM2.5 air pollution exposure and colorectal cancer incidence in wildfire-impacted areas in the United States

    Joyce Gong: Development of a tool for understanding the impact of gender-affirming care on cancer risks for trans and gender-diverse patients

    Kimberly Greco, BS, MPH: A semi-supervised framework to enhance rare disease phenotyping from electronic health records

    Shweta Gupta, PhD: Exosome-mediated smart and targeted drug delivery for cancer theranostics

    Nicolas Kubista, MSc: Methods and software for penetrance estimation in family-based cancer penetrance studies

    Phuong Anh Le, MS: Inflammatory and insulinemic dietary patterns during adolescence and risk of invasive breast cancer among US women

    Daniel Lee-Hassett: Effect of a 16-week multimodal exercise intervention on muscular strength in breast, prostate and colorectal cancer survivors

    Nan Lin, PhD: The role of distress-related metabolic dysfunction in ovarian cancer development

    Qiang Liu, MD: Pre- and post-diagnostic healthy lifestyle and cardiovascular disease among breast cancer survivors

    Colleen McGrath, MS: Caregiver characteristics and quality of life in patients with prostate cancer in the Detroit Research of Cancer Survivors study

    Jennifer Mongiovi, PhD, MS: Contraception and ovarian cancer tumor immune profiles

    Emma O’Neil, BA, BS: Adapting the tumor board model for serious mental illness and cancer: Identification and enrollment of patients at the North Shore

    Andrea Romanos-Nanclares, PhD: Dietary insulinemic potential and survival after breast cancer diagnosis

    Maria Sol Rosito, PhD: Automated deduplication of pedigree datasets: A tree-based machine learning approach

    Patrick Ryan, PhD: ATG4B is an oncogene in lung adenocarcinoma

    Daniel Schwartz, PhD: Improved risk stratification of smoldering multiple myeloma (SMM) using trajectory data in the PANGEA 2.0 model: A multicenter study in 1,431 participants

    Koki Takabatake, MPH: Age-specific risk of ovarian cancer in families with PALB2

    Ehab Tawfils, BPharm: Alcohol intake and risk of esophageal adenocarcinoma: a pooled analysis of 14 prospective cohort studies

    Satoko Ugai, MD, PhD, MPH: Association of Bacteroides fragilis and enterotoxigenic Bacteroides fragilis with specific T-cell subsets in the colorectal carcinoma microenvironment

    Xingyan Wang, PhD: Genetic variants associated with ductal carcinoma in situ in women from the UK Biobank

    Siqi Wang, MS

    Kelcie Willis, PhD: Coping in caregivers of patients with primary malignant brain tumors: A mediation analysis of a randomized controlled trial

    Mingxiao Yang, MD, PhD: Tai Chi for chemotherapy-induced peripheral neuropathy: clinical trial design informed by existing evidence from non-cancer population

    Sayeda Yasmin-Karim, MD, MS, PhD: Aerosol delivery of Hesperetin loaded nanoparticles and immunotherapy increases survival in a murine lung cancer model

    Xinyuan (Cindy) Zhang, PhD: Association between per- and polyfluoroalkyl substances and liver cancer risk

    Alessandro Zito, PhD: Compressive Bayesian non-negative matrix factorization for mutational signature analysis


    5:00 pm

    Award Announcement

    Best Oral Presentation

    Most Innovative Idea

    Best Poster Presentation

February 10, 2023 | 1:00 - 4:30 pm

Keynote Speaker:

Jennifer Temel, MD
Clinical Director of Thoracic Oncology
Co-Director, Cancer Outcomes Research and Education Program
Professor of Medicine at Harvard Medical School
Massachusetts General Hospital

2023 Award Winners

Best Oral Presentation: Mahnum Shahzad (HMS)

Most Promising Idea: Martin Hemberg, PhD (BWH)

Best Poster Presentation: Sarika Aggarwal (HSPH)

Best Online Poster: Nichole Gutierrez (MGH)

  • 2023 Agenda

    1:00 – 1:05 pm (5 minutes)

    Introductions 

    Greetings from Dr. Laurie Glimcher, MD
    Richard and Susan Smith Professor, Medicine, Harvard Medical School
    President and CEO, Office of the President, Dana-Farber Cancer Institute
    Director, Harvard Cancer Consortium, Executive Committee
    President, DFCI, Governance Committee

    Acknowledgment of PATHFINDER Director Lee Nadler, MD
    Virginia and D.K. Ludwig Professor of Medicine, Medicine, Harvard Medical School
    Chief, Medical Oncology, Brigham and Women's Hospital
    Senior Vice President, Experimental Medicine, Dana-Farber Cancer Institute
    Dean, Clinical and Translational Research, Harvard Catalyst - The Harvard Clinical and Translational Science Center
    PMC Chair, Adult Oncology, Dana-Farber Cancer Institute


    1:05 – 1:30 pm (25 minutes)

    Keynote Speaker

    Jennifer Temel, MD
    Clinical Director of Thoracic Oncology
    Co-Director, Cancer Outcomes Research and Education Program
    Professor of Medicine at Harvard Medical School
    Massachusetts General Hospital


    1:30 – 2:00 pm (30 minutes)

    Panel Discussion

    Moderator

    Jennifer Mack, MD, MPH
    Associate Chief in the Division of Population Sciences at Dana-Farber
    Director of Pediatric Population Sciences at Dana-Farber/Boston Children’s Hospital
    Associate Professor of Medicine
    Faculty Vice President for the Office for Faculty Development, Professionalism, and Inclusion (OFDPI)
    Associate Professor in Pediatrics at Harvard Medical School 

    Panelists

    Areej El-Jawahri, MD
    Associate Director, Cancer Outcomes Research and Education Program
    Director, Bone Marrow Transplant Survivorship Program
    Associate Professor of Medicine
    Massachusetts General Hospital

    Deborah Forst, MD
    Assistant Professor of Neurology
    Massachusetts General Hospital

    Jamie M. Jacobs, PhD
    Assistant Professor of Psychology, Psychiatry, Harvard Medical School
    Director, Caregiver Research, Cancer Outcomes Research Program, Massachusetts General Hospital

    Jessica Bauman, MD
    Chief, Division of Head and Neck Medical Oncology
    Associate Professor, Department of Hematology/Oncology
    Director, Hematology/Oncology Fellowship Training Program
    Fox Chase Cancer Center 


    2:00-2:10 pm (10 minutes)

    Break


    2:10-3:30 pm (80 minutes)

    Oral Presentation

    Charlotte Roscoe, PhD: Impact of a hypothetical policy to reduce particulate matter air pollution on all-cause and cause-specific mortality in Black and white men with prostate cancer: A registry-based cohort study

    Marouen Ben Guebila, PhD: Pan-cancer network analysis reveals that lactate dehydrogenase B contributes to Warburg effect by activation in its nonpreferential biochemical direction

    Siwen Wang, MD: A prospective cohort study of infertility and cancer incidence

    Aimee Huang, MD, MPH: Disparities in cancer incidence by sexual orientation

    Stephen Lo, PhD: A randomized controlled trial of a novel cognitive-behavioral treatment utilizing exposures and pulse oximetry biofeedback for shortness of breath in lung cancer

    Mahnum Shahzad: Timing and quality of evidence for oncology indications approved using the FDA’s Accelerated Approval Program

    Yujia Lu: Imaging-based visceral adipose tissue volume (VAT) and cancer risk in the UK Biobank cohort

    Zeba Ahmad, PhD, MA, EdM: Associations among symptom distress, coping, psychological well-being, and medication adherence in patients with breast cancer taking adjuvant endocrine therapy

    Emma McGee, MSc: Methodological challenges in estimating the long-term effects of lifestyle interventions for cancer survivors

    Martin Hemberg, PhD: Leveraging sequences missing from the human genome to diagnose cancer


    3:30– 4:30 pm (60 minutes)

    Pathfinder Poster Session
    Poster session is sponsored by Pathfinder

    Pathfinder Lightning Talk
    Susan Krusell (Program Manager) and Kate Varteresian (Education Specialist)


    In-person posters:

    Poster Abstract Booklet

    Sarika Aggarwal: Cause-specific risk of hospital admission related to floods in older adults [Poster] [Video]

    Sunjeong Bae, MD: Marine Omega-3 Fatty Acid Intake, The Gut Microbiome, And Their Interaction With Chronic Systemic Inflammation In A Cohort Of Adult Men [Poster] [Video]

    Kristen Brantley, PhD: Second primary breast cancer among young breast cancer survivors [Poster] [Video]

    Naiyu Chen, MPH: Marital status, living arrangement, and overall survival among individuals with advanced prostate cancer in the IRONMAN cohort [Poster] [Video]

    Cami Christopher, MPH: Physical Activity Before and After Cancer Diagnosis and Total and Cause-Specific Mortality [Poster] [Video]

    Jingwen Dong: Association between the Dietary Inflammatory Index and Esophageal Precancerous Lesions and Esophageal Cancer: A Cross-Sectional Study [Poster] [Video]

    Wenyu Gao, PhD: Better Base Qualities for Next-Generation Sequencing [Poster] [Video]

    Paola Gonzalo-Encabo, PhD: Exercise training on metabolic-related biomarkers in breast cancer patients undergoing chemotherapy [Poster] [Video]

    Daniel Hall, PhD: Feasibility and Acceptability of IN FOCUS: A Synchronous, Virtual Group Intervention for Fear of Cancer Recurrence and Uncertainty in Survivorship [Poster]

    Claire Kim, PhD, MPH: Population-based incidence rates of prostate cancer molecular subtypes by race [Poster] [Video]

    Pin-Ji Lei, PhD: Breast cancer cell MHC class II-mediated tumor progression and immune regulation in the draining lymph nodes [Poster] [Video]

    Kevin Ma, DDS: The use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) was associated with significantly lower all-cause mortality in patients with cancer [Poster] [Video]

    Vanessa Merker, PhD: Access to Specialized Neurofibromatosis Clinics in the United States: A National Survey of Neurofibromatosis 1 (NF1) Patients and Caregivers [Poster]

    Jennifer Mongiovi, PhD, MS: Contraception and ovarian cancer risk by tumor immune profiles [Poster] [Video]

    Manan Nayak, PhD: Exploring the role of Cannabidiol (CBD) in cancer care both from the medical oncologists perspective as well as from the cancer patients [Poster] [Video]

    Phillip Nicol: Model-based dimensionality reduction for single-cell RNA-seq with generalized bilinear models [Poster] [Video]

    Vedant Shukla: Assessment of Intratumoral and Stromal Infiltrating Lymphocytes in the Various Subtypes of Breast Cancer Post-Neoadjuvant Chemotherapy in Western India [Poster] [Video]

    Xinan Wang, PhD, MS: Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification and prediction [Poster]

    Yaguang Wei, PhD: Additive effects of 10-year exposures to PM2.5 and NO2 on cancer incidence in American older adults [Poster] [Video]


    Online only posters:

    Elisa Botting: Changes of clinical care for patients with advanced prostate cancer in the United States, United Kingdom, and Spain during the COVID-19 pandemic [Poster] [Video]

    Audrey Cantillon: Resiliency program needs among fathers of children and youth with special healthcare needs [Poster] [Video]

    Maria Cote, MD: Pre-Liver Transplantation Locoregional Therapy in Patients with Hepatocellular Carcinoma [Poster] [Video]

    Brigitte Durieux: Goals of Care Documentation in the Structured and Unstructured Electronic Medical Record: Qualitative Observations and Implications for Practice [Poster] [Video]

    John Gardiner: Circuit, Interval-based Exercise reduces fatigue in Breast, Prostate, and Colorectal Cancer Survivors [Poster] [Video]

    Nicole Gutierrez: Framework-guided cultural adaptation of a nurse-led intervention (INITIATE) to increase initiation of adjuvant endocrine therapy for patients with breast cancer [Poster] [Video]

    Michaela Markwart: Acceptability of an adapted resiliency program for adolescent and young adult cancer survivors (AYA) [Poster] [Video]

    Yan Si: Perceived ability to cope and its impact on anxiety and depression on adolescent and young adult cancer survivors [Poster] [Video]

    Yi Zhang: MetaTiME: Meta-components of the Tumor Immune Microenvironment [Poster] [Video]


    4:30 pm

    Award Announcement

  • 2022

    January 19, 2022 | 1:00 - 4:00 pm

    Watch Event Recording

    Keynote Speaker:

    Ann H. Partridge, MD, MPH
    Professor of Medicine at Harvard Medical School
    Vice Chair of Medical Oncology at Dana-Farber Cancer Institute Director of the Adult Survivorship Program


    2022 Agenda

    1:00 - 1:05 pm

    Introduction 


    1:05 - 1:30 pm

    Keynote Speaker:

    Ann H. Partridge, MD, MPH
    Professor of Medicine at Harvard Medical School
    Vice Chair of Medical Oncology at Dana-Farber Cancer Institute Director of the Adult Survivorship Program  

    Talk Title: "Improving Care and Outcomes for Young Women with Breast Cancer: From Observation to Intervention"

    Biography: 
    Ann Partridge, MD, MPH is a Professor of Medicine at Harvard Medical School, and Vice Chair of Medical Oncology at Dana-Farber Cancer Institute, where she also serves as Director of the Adult Survivorship Program and leads the Program for Young Women with Breast Cancer. As a medical oncologist and clinical researcher, she has sought to improve the care and outcomes of patients with cancer by conducting research, and by developing innovative clinical programming.

    Dr. Partridge serves in leadership roles nationally and internationally including as co-chair of the Breast Committee of the Alliance for Clinical Trials in Oncology and co-chair of the biennial ESMO-ESO sponsored Breast Cancer in Young Women Conference. She also served as Chair of the Center for Disease Control and Prevention (CDC) Advisory Committee on Breast Cancer in Young Women from 2010-17. She has received prior awards and grants including a Champions of Change award from the White House, an ASCO Improving Cancer Care Grant, the CDC Carol Friedman Award, the American Association for Cancer Research (AACR) Outstanding Investigator Award for Breast Cancer, and the Ellen L. Stovall Award in Cancer Survivorship from ASCO, and the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School.

    After graduating from Georgetown University, Dr. Partridge received her medical degree from Cornell University Medical College, pursued an internal medicine residency at the Hospital for the University of Pennsylvania, and completed Medical Oncology and Hematology fellowship at Dana-Farber/Partners CancerCare. She earned a Master of Public Health degree at the Harvard School of Public Health.


    1:30 - 2:00 pm

    Panel Discussion

    Tal Sella (tal_sella@dfci.harvard.edu)
    He received his medical degree from Tel Aviv University Sackler and with his medical oncology residency at Sheba Medical Center in Tel-HaShomer completed and a fellowship grant from APF, Dr. Tal Sella was accepted to the Advanced Fellowship program in breast oncology at the prestigious Dana-Farber Cancer Institute in Boston, MA.

    Tamryn Gray (Tamryn_gray@dfci.harvard.edu) 
    Tamryn Gray is an Instructor in Medicine at Harvard Medical School within the Department of Psychosocial Oncology and Palliative Care at Dana-Farber Cancer Institute and the Department of Medicine (Division of Palliative Medicine) at BWH. She also holds joint roles as a research scientist within the Phyllis F. Cantor Center for Nursing and Patient Services Research and a clinical-administrative role as a Clinical Nurse Specialist in the Division of Stem Cell Transplantation and Cellular Therapies, Department of Medical Oncology at DFCI.

    Peter Miller  (Pmiller4@partners.org)
    Peter Miller grew up in Atlanta and moved to Cambridge after high school where he completed his undergraduate degrees in Chemical Engineering and Biology at the Massachusetts Institute of Technology. He completed his MD and PhD at Harvard Medical School where he studied leukemia stem cells in the laboratory of Gary Gilliland and Benjamin Ebert. After graduation, he completed an internal medicine residency at Brigham and Women's Hospital and fellowship in medical oncology at the Dana-Farber Cancer Institute / Massachusetts General Hospital combined program. His research focuses on the biology of myeloid malignancies and he is clinically part of the leukemia program at Dana-Farber Cancer Institute.


    2:00 - 2:45 pm

    Oral Presentations 

    Breakout Room 1:

    David Lee: Prevalence of monoclonal gammopathies, including an age-related monoclonal gammopathy of indeterminate potential (MGIP), and their associated risk factors and clinical outcomes: results of a screening study by mass spectrometry in a high-risk population

    Sofia Vega: Expanding Bayesian Methods to Estimate Causal Effects of Environmental Exposures on Childhood Leukemia

    Andrea Romanos-Nanclares: Insulinemic Potential of Diet and Risk of Total and Subtypes of Breast Cancer Among US Women

    Pragya Kakani: The impact of physician-hospital integration on spending and quality of oncology care

    Chaoran Ma: Association of Prostate Cancer Risk Variants with Gene Expression in Prostate Stroma

    Phillip Nicol: pcDiffPop: Robust identification of perturbed cell types in single-cell RNA-seq data


    Breakout Room 2:

    Jim Doolin: A Phase II Feasibility Study of Electronic Patient Reported Outcomes (ePROs) for Oral Cancer Directed Therapies (OCDT)

    Alexandra Bercow: NCCN Guideline-Discordant Care in Early-Stage Vulvar Cancer: A National Cancer Database Study

    Kristen Brantley: A metabolomic analysis of adiposity measures and pre- and postmenopausal breast cancer risk in the Nurses’ Health Studies

    Cheng Peng: Regular aspirin use, breast tumor characteristics and long-term breast cancer survival

    Bailey Vaselkiv: Intratumoral vitamin D signaling and lethal prostate cancer

    Qiaoli Wang: Weight loss and subsequent cancer diagnosis: a prospective cohort study


    2:45 - 3:30 pm

    Poster Session  

    Khalid Alkhatib: Racial and Ethnic Disparities in High-Risk Cancer Genetic Testing Awareness in the United States; Health Information National Trends Survey (HINTS) Analysis [Poster][Video]

    Naiyu Chen: Impact of Age, Race, and Family History on COVID-19 Related Changes in Breast Cancer Screening and Diagnostic Imaging among the Boston Mammography Cohort Study [Poster][Video]

    Lydia Chevalier: Evaluating Sensitive Symptoms in Young Adult Cancer Survivors: Feasibility and Acceptability of Sexual Health and Suicide Items Across Administration Modes [Poster][Video]

    Cami Christopher: Improved insulin resistance and adiponectin among minority cancer survivors through circuit, interval-based exercise [Poster][Video]

    Krinio Giannikou: Distinct oncogenic signatures in malignant PEComa and leiomyosarcoma identified by integrative RNA-seq and H3K27ac ChIP-seq analysis [Poster][Video]

    Tian Gu: Synthetic data integration by leveraging external summary-level data to improve the risk prediction of prostate cancer [Poster][Video]

    Corinne Jansen: Does the histologic carcinoma subtype correlate with outcomes in uterine carcinosarcoma? [Poster] [Video]

    Dong-Woo Kang: Impacts of aerobic exercise on cardiorespiratory fitness and biochemical progression in men with prostate cancer on active surveillance: a randomized controlled trial [Poster][Video]

    Claire King: Inequities in referrals to a breast cancer personalized risk assessment and reduction program at an academic medical center [Poster][Video]

    Mara Koelker: Impact of exercise on physical health status in bladder cancer patients [Poster][Video]

    Muhieddine Labban: Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations [Poster][Video]

    Daniel Lage: CONTINUUM: A Pilot Care Transition Intervention for Hospitalized Patients with Advanced Cancer [Poster][Video]

    Colleen McGrath: Health Behaviors among Older Men and Cancer Survivors during the COVID-19 Pandemic [Poster] [Video]

    Jennifer Mongiovi: Associations between intrauterine device and oral contraceptive use with ovarian cancer risk among 6 case-control studies from the Ovarian Cancer Association Consortium [Poster][Video]

    Eve Nagler: Scaling up tobacco control in India: Comparing smartphone to in-person training for implementing an evidence-based intervention to reduce tobacco use among schoolteachers: Study overview [Poster][Video]

    Kaitlin Nicholson: Patient-reported drivers of financial toxicity in gynecologic cancers: A focus group study [Poster][Video]

    Yuho Ono: Ampullary Neoplasia in Young Patients: Syndromic and non-syndromic associations [Poster][Video]

    Vineet Raghu: Validation of a deep learning-based model to estimate lung cancer risk from chest radiographs [Poster][Video]

    Takashi Shimizu: Associations of molecular characteristics with tumor-infiltrating lymphocytes in non-microsatellite instability-high colorectal cancer [Poster][Video]

    Alaina Shreves: Sleep problems among long-term prostate cancer survivors by metastatic disease status [Poster][Video]

    Tomotaka Ugai: Smoking and Colorectal Cancer Incidence by T cell, Macrophage, and Myeloid Cell Infiltrates in Cancer Tissue [Poster][Video]

    Rebekah Wilson: Impact of Exercise on the Complications of Corticosteroids in Patients with Graft-Versus-Host Disease following Allogeneic Stem Cell Transplantation: the RESTART Trial [Poster][Video]

    Yan Yan: Identifying strain-specific functional genes in colorectal cancer
    [Poster][Video]

    Yin Zhang: Incident early- and later-onset type 2 diabetes and risk of early- and later-onset cancer [Poster][Video]


    3:30 pm

    Award Announcement

  • 2021

    January 21, 2021 | 1:00 - 3:30 pm

    Watch Event Recording - Part 1 | Part 2

    Keynote Speaker:

    Brian Wolpin, MD, MPH
    Director, Gastrointestinal Cancer Center at Dana-Farber Cancer Institute
    Associate Professor of Medicine, Harvard Medical School


    2021 Agenda

    1:00 - 1:05 pm

    Introduction 


    1:05 - 1:30 pm

    Keynote Speaker:

    Brian Wolpin, MD, MPH
    Director, Gastrointestinal Cancer Center at Dana-Farber Cancer Institute
    Associate Professor of Medicine, Harvard Medical School 

    Talk Title: "Multidisciplinary research to advance the care of patients with gastrointestinal cancers"

    Biography:
    Dr. Wolpin received his medical degree from Harvard Medical School in 2001. He subsequently completed his residency in Internal Medicine at Brigham and Women's Hospital, and his fellowship in Medical Oncology at the Dana-Farber Cancer Institute.

    He joined the staff of DFCI and Brigham and Women's Hospital in 2007, where he is a medical oncologist and clinical investigator in the Center for Gastrointestinal Oncology. His research focuses on biomarkers and novel therapeutics in gastrointestinal malignancies, with a particular focus on pancreatic cancer.


    1:30 - 2:00 pm

    Panel Discussion
    Charlie Fuchs, Sapna Syngal. Matt Vander Heiden, and Kimmie Ng


    2:00 - 2:45 pm

    Oral Presentations - Hide Presenters

    • Jan Heng: Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer
    • Bryan Iorgulescu: Underutilization of Guideline-Recommended Mismatch Repair/Microsatellite Instability Biomarker Testing in Patients with Advanced Colorectal Cancer
    • Jane Liang: Aggregating across genes and cancers in Mendelian risk prediction modeling
    • David-Dan Nguyen: Impact of the COVID-19 pandemic on the delivery of Definitive Therapy for Cancer at Mass General Brigham
    • Naoko Sasamoto: Personalized cutpoints of CA125 to improve early detection of ovarian cancer in postmenopausal women
    • Konrad Stopsack: Batch effects in tumor biomarker studies using tissue microarrays: Extent, impact, and remediation
    • Oana Zeleznik: Circulating amino acids and amino acid-related metabolites and risk of breast cancer among predominantly premenopausal women
       

    2:45 - 3:30 pm

    Poster Session 

    • Saud AlDubayan: Expanding the diagnostic yield of germline genetic testing in cancer patients using deep learning
      Watch Presentation 
    • Alaina Bever: A prospective study of dietary flavonoid intake and risk of glioma in US men and women
      Watch Presentation
    • Kristen Brantley: Circulating Plasma Metabolites and Breast Cancer Risk
      Watch Presentation
    • Lucy Castellanos: The Epidemiology and Management Patterns of Pediatric Pituitary Tumors in the United States
      Watch Presentation
    • Naiyu Chen: Factors associated with screening completion among high-risk and underserved population in an early detection lung cancer screening program in Los Angeles County, California
      Watch Presentation
    • Zhe (Gigi) Fang: Development and validation of risk prediction models with plasma biomarkers for colorectal cancer incidence
      Watch Presentation
    • Sydney Grob: Transcriptome expression of vitamin D genes in tumors and risk of lethal prostate cancer
      Watch Presentation
    • Jan Heng: Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk
      Watch Presentation
    • Fidelia Ida: Resection for Locally Recurrent Brain Metastases by Propensity Score Matching in A Retrospective Cohort Study
      Watch Presentation
    • Zhimeng Jia: Barriers and Facilitators to Advance Care Planning Among Seriously Ill Chinese Americans and Their Caregivers
      Watch Presentation
    • Alana McGovern: 2S-Sub-TITE: An adaptive two-stage time-to-toxicity model for subgroup-specific dose finding in Phase I oncology trials
      Watch Presentation
    • Anna Plym: Rare germline variants within DNA repair genes and lethal prostate cancer in European and African American men
      Watch Presentation
    • Andrea Romanos-Nanclares: Healthful and unhealthful plant-based diets and risk of breast cancer in U.S. women: results from the Nurses’ Health Studies
      Watch Presentation
    • Alaina Shreves: Geographic Patterns in US Lung Cancer Mortality and Smoking
      Watch Presentation
    • Claire Sokas: “In the Shadow of COVID”:  Patient Perspectives on Surgical Delays in Breast and Prostate Cancer
      Watch Presentation
    • Bailey Vaselkiv: 5-alpha Reductase Inhibitors (5-ARIs) and prostate cancer mortality among men with regular access to screening and health care
      Watch Presentation
    • Kai Wang: Long-term colorectal cancer incidence and mortality after colonoscopy screening according to individuals’ risk profiles
      Watch Presentation
    • Xinan Wang: Association between tobacco smoking and tumor mutation burden in an advanced non-small cell lung cancer cohort
      Watch Presentation
    • Xinan Wang: Smoking history as a potential predictor of Immune Checkpoint Inhibitor (ICI) efficacy in metastatic Non-small cell lung cancer (NSCLC)
      Watch Presentation
    • Yin Zhang: Unrestrained eating behavior and risk of digestive system cancers: a prospective cohort study
      Watch Presentation
       

    3:30 pm

    Award Announcement

  • 2019

    November 4, 2019 | 9:00 - 1:00 pm

    View Event Slideshow

    Plenary Speaker:

    Irene M. Ghobrial, MD
    Attending Physician, Medical Oncology, Dana-Farber Cancer Institute
    Professor of Medicine, Harvard Medical School
    Director, Clinical Investigator Research Program, Dana-Farber Cancer Institute
    Director, Michele & Stephen Kirsch Laboratory

    2019 Award Winners

    Best Oral Presentation: Jennifer Spencer (HTCSPH)

    Best Poster: Jennifer Snaman (DFCI)

    Most Promising Idea: Yuxi Liu (HTCSPH)

    2019 Agenda


    9:00 - 9:15 am

    Introduction (Smith 308)


    9:15 - 10:00 am

    Keynote Speaker:

    Irene M. Ghobrial, MD
    Attending Physician, Medical Oncology, Dana-Farber Cancer Institute
    Professor of Medicine, Harvard Medical School
    Director, Clinical Investigator Research Program, Dana-Farber Cancer Institute
    Director, Michele & Stephen Kirsch Laboratory

    Biography:
    Dr. Ghobrial received her MD in 1995 from Cairo University School of Medicine, Egypt. She completed her Internal Medicine training at Wayne State University, Mich., and her Hematology/Oncology subspecialty training at Mayo Clinic College of Medicine, Minn. 

    She joined Dana-Farber in the field of Waldenstrom's macroglobulinemia and multiple myeloma in 2005. She is conducting research in the area of homing and migration of B cells and novel therapeutic agents in Waldenstrom's macroglbulinemia and multiple myeloma.


    10:00 - 10:15 am

    Q&A and Discussion


    10:15 - 10:30 am

    Coffee Break


    10:30 am - 11:45 pm

    Oral Presentations


    12:00 - 12:45 pm

    Poster Session and Reception (Yawkey Conference Center)


    12:45 - 1:00 pm

    Award Announcement

  • 2018

    December 12, 2018 | 9:00 - 1:00 pm

    Plenary Speaker:

    Elena Martinez, PhD 
    Associate Director, Population Science, Disparities and Community Engagement
    Co-Leader, Community Outreach & Engagement Professor, Family Medicine and Public Health, University of California-San Diego

    2018 Award Winners

    Best Oral Presentation: Emma McGee

    Most Promising Idea: Jacqueline Seddon

    Best Poster: Karl Tully

     

    2018 Agenda

    Harvard Medical School, Waterhouse Room, Gordon Hall


    9:00 - 9:15 am

    Introduction


    9:15 - 10:00 am

    Plenary talk by Elena Martinez, PhD
    "Building the Next Generation of Cancer Disparities Scientists: We are Counting on You to Make a Difference!"


    10:00 - 10:15 am

    Q&A and Discussion


    10:15 - 10:30 am

    Coffee Break


    10:30 am - 11:45 pm

    Oral Presentations

    • Camila Lopes-Ramos: Gene regulatory networks identify sex differences in colon cancer
    • Rachel Nethery: A causal inference framework for cancer cluster investigations with Bayesian estimation of causal standardized incidence ratios using publicly available data
    • Caleb Bae: Variant-level BRCA mutations risk prediction model
    • Alessandra Ferrario: Trends in availability and use of cancer medicines in six Asian countries working towards universal health coverage
    • Kaelo Moahi: Effect of HIV on Survival of Hodgkin Lymphoma: A Prospective Study in Botswana
    • Konrad Stopsack: Single-cell multiplex immunofluorescence to identify PI3K pathway activation in archival prostate cancer tissue from two prospective cohort studies
    • Oana Zeleznik: Mammogram-derived texture features and risk of breast cancer
    • Emma McGee: Cigarette Smoking, Alcohol Consumption, and Biliary Tract Cancer Risk: A Pooling Project of 26 Prospective Studies
    • Kayoll Galbraith-Gyan: Community stakeholder and practitioner perspectives on introducing HPV and biobanking programming for underserved communities: A community engaged approach

    12:00 - 12:45 pm

    Poster Session and Reception 

    • Olga Ehrlich: A Framework for Cancer Pain Social Processes and Poorly-Controlled Pain in the Hospice Caring Triad
    • Christina Nguyen: Oncology Care Delivery Systems
    • Allison Ringel: Immunomodulatory mechanisms in the tumor microenvironment
    • Xihao Hu: Landscape of B cell immunity and related immune evasion in human cancers
    • Xia Xiang: Circulating vitamin D and risk of breast and prostate cancer: a Mendelian randomization study
    • Marieke Krimphove: Variation and Correlation of Facility-level Probabilities of Treatment in Men with Low- risk Prostate Cancer and Men with Limited Life Expectancy
    • Lucia Petito: Emulating randomized trials in SEER-Medicare: a causal approach
    • Yered Pita-Juarez: Modeling the effect of copy number alterations in gene expression using matching normal tissues
    • Karl Tully: The effect of androgen deprivation therapy on the risk of cognitive-related conditions in men with prostate cancer: a population-based study
    • Yunqi Yang: A Likelihood-based Approach to Assessing Frequency of Pathogenicity among Variants of Unknown Significance (VUS) in Susceptibility Genes
    • Zijie Zhao: Revealing Transcriptional Variation of Chromosomal Abnormalities at Single-cell Level
    • Jaihwan Kim: Clinical Factors Associated with Gastric Cancers among Lynch Syndrome Patients
    • Archana Agarwal: Impact of pure versus mixed metastatic urothelial carcinoma (mUC) histology on response with immune checkpoint inhibitors (ICIs).
    • Abha Aggarwal: High Glucose Environment Increases Cell Proliferation and Hexokinase-2 Copy Number in Anaplastic Thyroid Cancer
    • Andres Korat: A prospective analysis of red blood cell trans fatty acid levels and risk of non-Hodgkin lymphoma
    • Ingabire Balinda: HIV infection not associated with decreased anal cancer survival
    • Kristen Brantley: Plasma Estrogen Metabolites and Risk of Postmenopausal Breast Cancer in the Nurses’ Health Study
    • Vitoria De Carmo: Characterization of new regulators of S1PR1 endocytosis and signaling in endothelial cells
    • Barbra Dickerman: Guideline-based physical activity and survival among US men with nonmetastatic prostate cancer
    • Chi Gao: Validation of Breast Cancer Risk Prediction Models using Nurses Health and Nurse Health II Studies
    • Colby Hyland: The use of 18F-FDG PET/CT as an initial staging procedure for stage II-III breast cancer reduces false positives, costs, and time to treatment: a multicenter value analysis
    • Dong Hoon Lee: Prediagnosis dietary pattern and survival in patients with multiple myeloma
    • Matthew Mossanen: Examining the impact of complications on perioperative mortality after radical cystectomy
    • Patricia Saade-Lemus: Characteristics of older adults with locally advanced and metastatic pancreatic ductal adenocarcinoma who do and do not receive palliative chemotherapy
    • Naoko Sasamoto: Breastfeeding patterns and ovarian cancer risk: Results from the Ovarian Cancer Association Consortium
    • Jacqueline Seddon: Construction of pgRNA/CRISPR Cas9 Vectors for Validation of Synthetic Lethal Gene Interaction
    • Rui Song: Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and Colorectal Cancer Survival: Results from Two Prospective Cohort Studies
    • Yiwen Zhang: A prospective study of inflammation, focal atrophy, and lethal prostate cancer
    • Jill Ronacarati - Housing Boston’s Rough Sleepers: outcomes from a 10-year prospective study
    • David Cote - Tea, coffee, and caffeine intake and risk of glioma
       

    12:45 - 1:00 pm

    Award Announcement 

  • 2017

    November 6, 2017 | 1:00 - 6:00 pm

    Plenary Speaker

    Paul Jacobsen
    Associate Director of the National Cancer Institute Division of Cancer Control and Population Science’s Healthcare Delivery Research Program

    2017 Award Winners

    Best Oral Presentation: Deirdre Tobias

    Most Promising Idea: Khansa Sidahmed

    Best Poster: Barbra Dickerman

    2017 Agenda


    1:00 - 1:15 pm

    Introduction


    1:15 - 2:15 pm

    Plenary talk by Paul Jacobsen: “Improving Cancer-Related Care and Outcomes: A Healthcare Delivery Research Agenda"


    2:15 - 2:30 pm

    Coffee break


    2:30 - 3:30 pm

    Short Oral Presentations

    Erin Cook: Effect of HPV Legislation to Increase Uptake of HPV Vaccination onTeen Sexual Behaviors

    MK Downer: Moderate alcohol intake and risk of lethal prostate cancer in the Health Professionals Follow-up Study

    Margaux Hujoel: Estimating prevalence of rare genetic mutations

    Catherine Marinac: Elucidating under-studied aspects of the link between obesity and multiple myeloma: a prospective assessment of the influence of the stability, trajectory, and distribution of body fatness

    Deirdre Tobias: Effect of randomized aspirin use in the Women’s Health Study on cancer incidence and mortality, by baseline inflammatory status

    David Yang: Androgen Deprivation Therapy and Risk of Rheumatoid Arthritis in Patients with Prostate Cancer

    Oana Zeleznik: Metabolomicanalysis of ovarian cancer riskinthe Nurses’ Health Studies: Identification of potentialnovel riskfactors of endometrioid/clear cell and mucinous tumors

    Cindy Zhou: Coffee consumption after prostate cancer diagnosis and survival among men in the Health Professionals Follow-up Study


    3:30 - 4:45 pm

    Poster Session

    Francisco Acevedo: Using Machine Learning and Natural Language Processing to Predict Cancer Risk after Multi-Gene Panel Testing

    Justin Brown: Muscle Wasting and Survival in Stage I-III Colorectal Cancer: A Population-Based Cohort Study (C-SCAN)

    Daniela Buscariollo: Impact of pre-diagnosis depressive symptoms and quality of life on treatment choice for ductal carcinoma in situ in older women.

    Barbra Dickerman: Obesity and risk of prostate cancer

    Hari Iyer: Gender, cancer type, and treatment delay in Botswana

    Robert Knoerl: Efficacy of the Electronic Self-Report Assessment – Cancer (ESRA-C)

    Melanie Kornides: A scale to measure parent satisfaction with provider communication about HPV vaccination: Psychometric properties and relationship to vaccination behaviors

    Elizabeth Loehrer: Serum 25-Hydroxyvitamin Dlevelsat diagnosis and overall survival in esophageal adenocarcinoma

    Michael Milligan: Imaging for Stage IA Non-Small Cell Lung Cancer (NSCLC)

    Prasad Patil: Incorporating Inter-Study Heterogeneity into the Training of Predictors

    Joshua Petimar: Recommendation-Based Dietary Indices and Risk of Colorectal Cancer in the Nurses’ Health Study and Health Professionals Follow-up Study

    Naoko Sasamoto: CA125 ovarian cancer prediction models

    Derek Shyer: Simulation study to compare performance of dual-agent dose-escalation methods in a pediatric oncology framework

    Khansa Sidhamed: A Pooled Analysis of Dietary Fiber Intake and Prostate Cancer Risk

    Cathy Wang: Genetic factors for Lynch Syndrome and colorectal cancer risk

    You Wu: Dietary fiber and breast cancer risk

    Jennifer Yland: Dietary intake of folate, methionine, and vitamin B6 in relation to ovarian cancer survival in the New England Case-Control Study

    Linying Zhang: Interactions between multiple myeloma cells and bone marrow stromal cells impact epigenetic profiles of multiple myeloma


    4:45 - 5:00 pm

    Award Ceremony and Closing Remarks by Dr. Giovanni Parmigiani

  • 2016

    November 14, 2016 | 1:00 - 6:00 pm

    Plenary Speaker:

    Karen Emmons
    Vice President for Research and Director,
    Kaiser Foundation Research Institute

    2016 Award Winners

    Best Oral Presentation: Kathryn Wilson

    Most Promising Idea: Peter James

    Best Poster: Aymen Elfiki

    2016 Agenda


    2:00 - 2:05 pm

    Introduction


    2:05 - 3:05 pm

    Plenary talk by Karen Emmons, PhD
    “Realizing the Potential of Cancer Prevention in a Precision Era.”


    3:05 - 3:20 pm

    Coffee break


    3:20 - 4:45 pm

    Short Oral Presentations

    Garcia de Albeniz: Colonoscopy and risk of infective endocarditis in the elderly

    Peter James: Light at night and breast cancer incidence in the Nurses' Health Study II

    Loren Saulsberry: The impact of breast density notification laws on the use of supplemental breast cancer screening procedures

    Helian Feng: A multi-tissue transcriptome-wide association study of breast cancer identifies 29 novel breast cancer susceptibility loci

    Kathryn Wilson: Baseline prostate-specific antigen (PSA) levels in midlife predict aggressive prostate cancer in African-American men

    Salome Kuchukhidze: Knowledge and interest in lung cancer screening among community health center current and former smokers

    Maud Fagny: A network-based approach to eQTL interpretation and SNP functional characterization

    Catherine Marinac: Associations between timing of meals, physical activity, light exposure, and sleep with body mass index in free-living adults

    Maxine Sun: Cognitive impairment after androgen deprivation therapy for advanced prostate cancer: a retrospective analysis and a pooled-analysis

    Thomas Madsen: Peeling and paring: an algorithm for computing carrier probabilities for an arbitrary number

    Mesfin Bekalu: Emotional and cognitive reactions to tobacco graphic health warnings (GHWs) and associated quit attempts among low socioeconomic position (SEP) populations


    4:45 - 5:00 pm

    Words from Dr. Laurie Glimcher, MD


    5:00 - 6:00 pm

    Poster Session (viewings, groups led by faculty, active discussions)

    David Cheng: Inverse probability weighting with a responseinformed calibrated propensity score: a robust and efficient approach for treatment effects in large observational studies

    Claire Kim: Stability and reproducibility of proteomic profiles measured with SOMAscan platform

    Anupriya Dutta: Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study

    Peter James: GPS-based exposure to greenness and objectively measured physical activity

    Prasanna Ananth: Providers perspectives on use of medical marijuana in pediatric oncology patients

    Anish Mehta: Mediators of disparities in survival among patients with non-small cell lung cancer

    Xia Jiang: Analysis of shared heritability and functional enrichment based on genome-wide association studies for five common cancers

    Trang VoPham: Environmental radon and breast cancer risk in the Nurses’ Health Study II

    Dana Footer: Pain in survivors of pediatric brain tumors

    Claire Pernar: Physical activity and risk of prostate cancer defined by TMPRSS2:ERG

    Ericka Ebot: Gene expression profiling of prostate tissue identifies biological pathways associated with TMPRSS2:ERG gene fusion

    Sarah Markt: Age ≥ 40 years is associated with adverse outcomes in metastatic germ cell cancer despite appropriate intended chemotherapy

    Aymen Elfiky: Short-term mortality prediction using a machine learning algorithm for patients initiating chemotherapy

    Giselle Perez-Lougee: Promoting resiliency among palliative care clinicians: stressors, coping strategies, and training needs

    Giselle Perez-Lougee: Mental health insurance preferences, coverage and utilization among childhood cancer survivors

    Zoe Guan: BRCA-Gail: a combination model for breast cancer risk prediction

    Theo Huang: Using frailty models to improve familial cancer risk prediction

    Jiabei Yang: A tool to predict cancer risk with uncommon genetic mutations

    Shoshana Rosenberg: Employment trends in young women following a breast cancer diagnosis

    Maxine Chen CDNM: Transcriptome-wide association study of prostate cancer risk.

    Joseph Paulson: Tissue-aware RNA-Seq processing and normalization for heterogeneous and sparse data

    Marieke Kuijjer: Modeling the effects of gene regulation on glioblastoma survival using individual patient networks

    Camila Lopes-Ramos: Sexual dimorphism in colon cancer revealed by gene regulatory networks

    Evan Busch: Mutations in genes related to epithelialmesenchymal transition in carcinomas

    Candice Chow: Relapse as a risk factor for anxiety in adolescent and young adult survivors of pediatric brain tumors

    Mary Kathryn Downer: Aspirin use and the risk of lethal prostate cancer in the Physicians' Health Study

    Kevin Kensler: Androgen receptor expression and breast cancer survival in the Nurses’ Health Study cohorts

    Megan Rice: Texture variation on a mammogram and risk of breast cancer

    Natalie DuPre: Particulate matter exposures in relation to breast cancer survival

    Ilaria Domenicano: A Bayesian information-driven phase I/II dose-finding design

    Mollie Barnard: Analgesic use and risk of ovarian cancer in the Nurses’ Health Studies

    Sarah Mantwill: Interpersonal communication about graphic health warning labels in a vulnerable population – Predictors and smoking-related consequences of conversations


    6:00 - 6:10 pm

    Closing Remarks by Dr. Frank Hu, MD


    6:10 - 6:15 pm

    Award Announcement by Dr. Giovanni Parmigiani, PhD

Home

Research Support

  • Human Subjects Research
  • Core Facilities
  • Research Programs
  • HCC SPOREs

About HCC

  • Our Mission
  • Member Institutions
  • Leadership & Administration
  • Community Outreach
  • Training & Education

General

  • Brand Standards
  • News
  • Events
  • Funding
  • Member Search

HCC Offices

  • COE: Community Outreach and Engagement
  • HCC Administration
  • Communications
  • ODQ: Office of Data Quality
  • OHRS: Office for Human Research Studies
  • Pathfinder
  • RIO: Research Informatics Operations

Central Administration

450 Brookline Avenue, BP2139 Boston, MA 02215

Phone
617 632 2100
Toll Free
877 420 3951
Fax
617 632 4452
Email
Get in touch
(opens in new window)
  • Privacy
  • Legal Notices

Copyright © 2026 Harvard Cancer Consortium. All Rights Reserved.